Literature DB >> 1441182

Preventive treatment against toxocarosis in bovine calves.

J A Roberts1.   

Abstract

Treatment of bovine calves 10-16 days old with an anthelmintic which is effective against immature Toxocara vitulorum killed the parasites, there was no new infection and recontamination of the environment was precluded. When the management of the program was delegated to the livestock officers, approximately 3% of calves scheduled for treatment developed patent infections. The prevalences of toxocarosis on the different farms were correlated with annual rainfall, probably because the longer dry periods associated with lower rainfall killed infective eggs in the environment. The treatment schedules prevailing before the study commenced were ineffective. The prevalence of toxocarosis in the bovine calves on farms in the area with an annual rainfall of about 1000 mm was lower than that in buffalo calves studied previously in the same area.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1441182     DOI: 10.1016/0304-4017(92)90149-4

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  4 in total

1.  Toxocara vitulorum intestinal impaction in male White Fulani calves: a case report from Nigeria.

Authors:  Z Audu; S E Abalaka
Journal:  J Parasit Dis       Date:  2019-06-18

2.  Toxocara vitulorum in a bison (Bison bison) herd from western Canada.

Authors:  Murray R Woodbury; Shelagh Copeland; Brent Wagner; Champika Fernando; Janet E Hill; Cathy Clemence
Journal:  Can Vet J       Date:  2012-07       Impact factor: 1.008

3.  A survey to detect Toxocara vitulorum and other gastrointestinal parasites in bison (Bison bison) herds from Manitoba and Saskatchewan.

Authors:  Murray R Woodbury; Brent Wagner; Elad Ben-Ezra; Dale Douma; Wendy Wilkins
Journal:  Can Vet J       Date:  2014-09       Impact factor: 1.008

4.  Incidence of Toxocara vitulorum in creole Calves of Guadeloupe.

Authors:  Maurice Mahieu; Michel Naves
Journal:  Trop Anim Health Prod       Date:  2008-05       Impact factor: 1.559

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.